Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aesica
Newcastle upon Tyne, United Kingdomaesica-pharma.co.uk ↗
- Ownership
- Private
- Employees
- ~1300
- Development stage
- Other
01
Overview
Aesica was a European CDMO specializing in APIs and finished dose manufacturing, supplying top pharmaceutical companies and producing widely used drugs such as flurbiprofen; it operated six sites and was acquired in 2014 by Consort Medical for approximately $370M, then later integrated into the parent company's device/pharma business.
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyRheumatologyInfectious DiseasesOtherHematology
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
Top 20 global pharmaceutical companies
Beyond the preview
Go deeper on Aesica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aesica.